Scarica l'app Stockscreener
98.81
4.16%
3.95
Dopo l'orario di chiusura:
98.81
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$94.86
Aprire:
$95.96
Volume 24 ore:
2.06M
Relative Volume:
1.20
Capitalizzazione di mercato:
$18.85B
Reddito:
$8.41B
Utile/perdita netta:
$760.80M
Rapporto P/E:
25.66
EPS:
3.8513
Flusso di cassa netto:
$1.05B
1 W Prestazione:
+4.69%
1M Prestazione:
+5.14%
6M Prestazione:
+6.20%
1 anno Prestazione:
-4.97%
Intervallo 1D:
$95.42
$98.92
Intervallo di 1 settimana:
$93.85
$98.92
Portata 52W:
$79.12
$106.88
Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile
Nome
Zimmer Biomet Holdings Inc
Settore
Industria
Telefono
(574) 267-6131
Indirizzo
345 EAST MAIN STREET, WARSAW, IN
Compare ZBH vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ZBH
Zimmer Biomet Holdings Inc
|
98.81 | 18.85B | 8.41B | 760.80M | 1.05B | 3.8513 |
ABT
Abbott Laboratories
|
102.51 | 177.38B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
96.59 | 123.55B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.08 | 117.79B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
46.01 | 66.68B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
90.09 | 51.93B | 6.30B | 1.07B | 1.09B | 1.8406 |
Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-10-07 | Iniziato | Barclays | Equal Weight |
| 2026-07-28 | Iniziato | UBS | Buy |
| 2026-07-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2026-03-23 | Downgrade | BTIG Research | Buy → Neutral |
| 2026-02-20 | Iniziato | William Blair | Mkt Perform |
| 2026-01-09 | Downgrade | Goldman | Neutral → Sell |
| 2026-01-06 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2026-01-05 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-11-06 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-09-18 | Iniziato | Rothschild & Co Redburn | Buy |
| 2025-07-15 | Aggiornamento | Roth Capital | Neutral → Buy |
| 2024-12-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-09-10 | Iniziato | Wolfe Research | Peer Perform |
| 2024-07-01 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-10-20 | Iniziato | ROTH MKM | Neutral |
| 2023-08-28 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-05-03 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-04-11 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-03-31 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-03-29 | Iniziato | UBS | Sell |
| 2023-03-10 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-01-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-05 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Underweight |
| 2022-10-12 | Iniziato | Jefferies | Underperform |
| 2022-05-27 | Downgrade | Needham | Buy → Hold |
| 2022-04-13 | Downgrade | Truist | Buy → Hold |
| 2022-04-01 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Underperform |
| 2022-03-02 | Downgrade | Loop Capital | Buy → Hold |
| 2022-02-08 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2022-02-08 | Reiterato | Citigroup | Buy |
| 2022-02-08 | Reiterato | Deutsche Bank | Hold |
| 2022-02-08 | Reiterato | JMP Securities | Mkt Outperform |
| 2022-02-08 | Reiterato | JP Morgan | Neutral |
| 2022-02-08 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2022-02-08 | Reiterato | Stifel | Buy |
| 2022-02-08 | Reiterato | Truist | Buy |
| 2022-02-08 | Reiterato | UBS | Neutral |
| 2022-02-08 | Reiterato | Wells Fargo | Underweight |
| 2022-02-02 | Downgrade | UBS | Buy → Neutral |
| 2022-01-19 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2022-01-10 | Downgrade | Mizuho | Buy → Neutral |
| 2022-01-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2021-12-09 | Downgrade | Needham | Strong Buy → Buy |
| 2021-12-07 | Iniziato | Loop Capital | Buy |
| 2021-11-23 | Downgrade | Argus | Buy → Hold |
| 2021-09-14 | Ripresa | Raymond James | Mkt Perform |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-09 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2021-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-12-18 | Reiterato | Needham | Strong Buy |
| 2020-10-20 | Iniziato | Northland Capital | Market Perform |
| 2020-09-11 | Iniziato | Wolfe Research | Outperform |
| 2020-08-05 | Reiterato | Needham | Strong Buy |
| 2020-04-28 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2020-04-07 | Reiterato | Needham | Strong Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2020-01-07 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2020-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2019-12-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2019-10-07 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-09-18 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2019-08-12 | Aggiornamento | Argus | Hold → Buy |
| 2019-07-30 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-07-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-06-11 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2019-04-24 | Aggiornamento | Needham | Buy → Strong Buy |
Mostra tutto
Zimmer Biomet Holdings Inc Borsa (ZBH) Ultime notizie
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
ZBH6004609 Bond Profile: Coupon and Redemption - TradingView
Form 4 Zimmer Biomet Holdings Inc: Devdatt Kurdikar (Director) For: 30 September - Investing.com India
Form 4 Zimmer Biomet Holdings Inc: Devdatt Kurdikar (Director) For: 30 September - Investing.com Nigeria
Form 4 Zimmer Biomet Holdings Inc: Michael J. Farrell (Director) For: 30 September - Investing.com Nigeria
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Stock Has Average Price Target of $103.33 - MarketBeat
Zimmer Biomet (NYSE:ZBH) Share Price Crosses Below Fifty Day Moving AverageTime to Sell? - MarketBeat
Zimmer Biomet Q3 2026 Earnings Date and Estimates - MarketBeat
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Sept. 3: Zimmer Biomet moving HQ, donating former one to area college - KPCNews
Zimmer Biomet extends exclusive deal to distrib... - Pluang
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT - PR Newswire
ZIMMER BIOMET AND THINK SURGICAL EXTEND EXCLUSIVE DISTRIBUTION AGREEMENT - Morningstar
Zimmer Biomet Holdings Inc. R (ZIM.MU) Q2 FY2026 earnings call transcript - Yahoo Finance
Surgical Equipment & ConsumablesDiversified Stocks Q2 Results: Benchmarking Zimmer Biomet (NYSE:ZBH) - Yahoo Finance
Is It Too Late to Buy Zimmer Biomet Holdings Inc (ZBH) After 3.4% Rally? GF Value Says Undervalued - GuruFocus
Zimmer Biomet gains as investors weigh analyst optimism and prior guidance lift - Quiver Quantitative
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Form 4 Zimmer Biomet Holdings Inc For: 12 October By Investing.com - Investing.com Nigeria
Should Value Investors Buy Zimmer Biomet (ZBH) Stock? - Zacks Investment Research
Should Value Investors Buy Zimmer Biomet (ZBH) Stock? - Yahoo Finance
Leerink Partners Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $97 - Moomoo
Leerink Partners Adjusts Price Target on Zimmer Biomet to $97 From $106 - Yahoo Finance
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet (ZBH) is a Top-Ranked Value Stock: Should You Buy? - Zacks Investment Research
Zimmer Biomet Holdings Inc Share PriceZBH, RNS News, Articles, Quotes, & Charts (NYSE:ZBH) - Proactive financial news
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - Investing News Network
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Are Investors Undervaluing Baxter International (BAX) Right Now? - Zacks Investment Research
On Nov. 4, Q3 results release will be available at 6:30 a.m. ET before Zimmer Biomet's webcast. - Stock Titan
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - themountaineer.com
Zimmer Biomet Announces Webcast and Conference Call of Third Quarter 2026 Financial Results - Yahoo Finance
A Look at Zimmer Biomet Holdings Inc (ZBH) After 3.7% Gain -- GF Value $125.41 vs Price $91.57 - GuruFocus
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
932 and 480 shares are withheld for taxes as Zimmer Biomet (ZBH) stock awards convert. - Stock Titan
Options on 7,035 shares expire in 2032 for Zimmer Biomet (ZBH) executive Brian Hatcher. - Stock Titan
Fully vested options are among Americas president Gary Craig Campbell's Zimmer Biomet (ZBH) holdings. - Stock Titan
Citi Initiates 90-Day Watch on Zimmer Biomet (ZBH) Ahead of Q3 E - GuruFocus
Zimmer Biomet Holdings Inc. (ZIM.SG) Q2 FY2026 earnings call transcript - Yahoo Finance
ZBH6004607 Bond Profile: Coupon and Redemption - TradingView
A director at Zimmer Biomet (ZBH) acquired 417.363 units payable in cash. - Stock Titan
A director acquires 306 cash-settled stock units at Zimmer Biomet (ZBH), payable in five annual installments. - Stock Titan
Director Arthur J. Higgins acquires 306.066 cash-settled units at Zimmer Biomet (ZBH). - Stock Titan
Director acquires 375.626 cash-settled stock units at Zimmer Biomet (ZBH). - Stock Titan
A director acquires 174 deferred stock units at Zimmer Biomet (ZBH), payable in shares after service ends. - Stock Titan
Director Kolli acquires 173.901 deferred stock units at Zimmer Biomet (ZBH). - Stock Titan
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - marketwatch.com
Zimmer Biomet stock after-hours at EUR 78.77 - AD HOC NEWS
Why Are Traders Reassessing Zimmer Biomet (NYSE:ZBH)? - Kalkine Media
CH147843074 Bond Profile: Coupon and Redemption - TradingView
Zimmer Biomet Holdings Inc Azioni (ZBH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Zimmer Biomet Holdings Inc Azioni (ZBH) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thornal Kevin R | Grp Pres-Global Business |
Sep 11 '26 |
Sale |
92.95 |
5,691 |
528,978 |
0 |
| Thornal Kevin R | Officer |
Sep 11 '26 |
Proposed Sale |
92.95 |
5,691 |
528,978 |
0 |
| Phipps Chad F | Officer |
Sep 04 '26 |
Proposed Sale |
98.35 |
3,000 |
295,050 |
0 |
| Phipps Chad F | See remarks below. |
Sep 04 '26 |
Sale |
98.35 |
3,000 |
295,050 |
65,231 |
| Thornal Kevin R | Grp Pres-Global Business |
Aug 01 '26 |
Option Exercise |
0.00 |
9,957 |
0 |
9,957 |
| Upadhyay Suketu | Former Officer |
Jul 16 '26 |
Proposed Sale |
92.86 |
7,668 |
712,050 |
0 |
| Upadhyay Suketu | Former Officer |
Jun 24 '26 |
Proposed Sale |
90.07 |
4,560 |
410,696 |
0 |
| Yi Sang | Group President, Asia Pacific |
May 29 '26 |
Sale |
82.64 |
5,000 |
413,216 |
27,251 |
| Yi Sang | Officer |
May 29 '26 |
Proposed Sale |
82.64 |
5,000 |
413,216 |
0 |
| Upadhyay Suketu | Former Officer |
May 19 '26 |
Proposed Sale |
86.38 |
5,373 |
464,120 |
0 |
4.85%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):